BWS
CYTK icon

Buck Wealth Strategies’s Cytokinetics CYTK Stock Holding History

Buck Wealth Strategies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-57
Closed -$1.68K – 122
2023
Q3 		$1.68K Hold
57
– – ﹤0.01% 318
2023
Q2 		$1.86K Hold
57
– – ﹤0.01% 240
2023
Q1 		$2.01K Buy
+57
New +$2.33K ﹤0.01% 182

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Buck Wealth Strategies's CYTK Position: Q4 2023 in Review

Buck Wealth Strategies sold out of Cytokinetics (CYTK) in Q4 2023, closing a stake of 57 shares — an estimated $1.68K sold.

Buck Wealth Strategies first reported a position in CYTK in Q1 2023 and held it in 3 quarters. The position peaked at $2.01K in Q1 2023. 347 funds tracked by Wall St. Rank hold CYTK as of Q4 2023.

  • Buck Wealth Strategies reported no remaining Cytokinetics position as of Q4 2023 after selling out during the quarter.
  • Buck Wealth Strategies sold 57 Cytokinetics shares in Q4 2023, an estimated $1.68K.
  • Buck Wealth Strategies first reported a position in Cytokinetics in Q1 2023 and held it in 3 quarters.
  • Buck Wealth Strategies's Cytokinetics position peaked at $2.01K in Q1 2023.
  • 347 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2023.

Based on Buck Wealth Strategies's 13F filing for Q4 2023, filed 23 Jan 2024.